Moreover, since many of these genes, including PNPLA3 and TM6SF2, have also been associated with NASH, it is questionable whether low-grade inflammation plays a major role in the connection between NAFLD and CVD. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.